Publications- Department of Haematology
2011
1.Alkindi S, Pathare A, Al-Madhani A, Al-Zadjali S, Al-Haddabi H, Al-Abri Q, Gravell D, Mathew M, Krishnamoorthy R. Neonatal Screening: Mean haemoglobin and red cell indices in cord blood from Omani neonates. Sultan Qaboos Univ Med J. 2011 Nov;11(4):462-9. Epub 2011 Oct 25. PMID: 22087394 [PubMed]
2.Alkindi S, Marchado N, Chopra P, Al-Huneini M, Mohamed K, Alfarsi M, Pathare A. Acute massive splenic infarction with complete liquefaction of the spleen in sickle cell disease. Hematol Oncol Stem Cell Ther. 2011;4(3):142-4.
3.Gowri V, Mathew M, Gravell D, AlFalahi K, Zakwani I, Ganguly SS, Pathare AV. Protein Z levels in pregnant Omani women: correlation with pregnancy outcome. J Thromb Thrombolysis. 2011 Nov;32(4):453-8.
4.Alkindi S, Arafa N, Al Okbi M, Pathare A. Complete recovery following sudden sensorineural hearing loss in a patient with sickle cell disease. Hematol Oncol Stem Cell Ther. 2011;4(2):97-9.
5.Al Okbi MH, Alkindi S, Al Abri RK, Mathew J, Nagwa AA, Pathare AV. Sensorineural hearing loss in sickle cell disease--a prospective study from Oman. Laryngoscope. 2011 Feb;121(2):392-6.
6.Krishnan L, Pathare A. Necrotizing enterocolitis in a term neonate following intravenous immunoglobulin therapy. Indian J Pediatr. 2011 Jun;78(6):743-4.
7.Alkaabi JK, Pathare A. Pattern and outcome of vascular involvement of Omani patients with Behcet's disease. Rheumatol Int. 2011 Jun;31(6):731-5.
8.Khabori MA, El-Emary M, Xu W, Guyatt G, Galal A, Kuruvilla J, Lipton J, Messner H, Gupta V. Impact of intensity of conditioning therapy in patients aged 40-60 years with AML/ myelodysplastic syndrome undergoing allogeneic transplantation. Bone Marrow Transplant. 2011 Apr;46(4):516-22.
9.Al-Farsi K, Al-Haddabi I, Al-Riyami N, Al-Sukaiti R, Al-Kindi S. Myelomatous Pleural Effusion: Case report and review of the literature. Sultan Qaboos Univ Med J. 2011 May;11(2):259-64. Epub 2011 May 15. PMID: 21969899
10.Puig N, Pintilie M, Seshadri T, al-Farsi K, Franke N, Keating A, Kuruvilla J, Crump M. High-dose chemotherapy and auto-SCT in elderly patients with Hodgkin's lymphoma. Bone Marrow Transplant. 2011 Oct;46(10):1339-44.
11.Alkindi S, Dennison D. Umbilical Cord Blood Banking and Transplantation: A short review. Sultan Qaboos Univ Med J. 2011 Nov;11(4):455-61. Epub 2011 Oct 25. PMID: 22087393
12.Alkindi S, Smith OP, Enright H. Successful Use of Alternative Anticoagulants in the Management of Heparin-induced Thrombocytopenia with Thrombotic Complications: Report of 5 cases and review of literature. Sultan Qaboos Univ Med J. 2011 Aug;11(3):391-8. Epub 2011 Aug 15.PMID: 22087382
13.Al Zadjali S, Wali Y, Al Lawatiya F, Gravell D, Alkindi S,Al Falahi K, Krishnamoorthy R, Daar S. The β-globin promoter -71 C>T mutation is a β+ thalassemic allele. Eur J Haematol. 2011 Nov;87(5):457-60.
14.Ahmed SO, Ghavamzadeh A, Zaidi SZ, Baldomero H, Pasquini MC, Hussain F, Alimoghaddam K, Almohareb F, Ayas M, Hamidieh A, Mahmoud HK, Elhaddad A, Ben Othman T, Abdelkefi A, Sarhan M, Abdel-Rahman F, Adil S, Alkindi S, Bazarbachi A, Benchekroun S, Niederwieser D, Horowitz M, Gratwohl A, El Solh H, Aljurf M. Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007. Biol Blood Marrow Transplant. 2011 Sep;17(9):1352-61.
15.Al Zadjali S, Daar S, AlKindi S, Gravell D, Al Haddabi H, Berbar T, Krishnamoorthy R. Hb Sheffield [β58(E2)Pro→His] in Oman: potential pitfall in genetic counseling. Hemoglobin. 2011;35(2):111-6.
16.Wali Y, Zadjali SA, Elshinawy M, Beshlawi I, Fawaz N, Alkindi S, Rawas A, Alsinani S, Daar S, Krishnamoorthy R. Severity ranking of non-deletional alpha thalassemic alleles: insights from an Omani family study. Eur J Haematol. 2011 Jun;86(6):507-11.
17.Karimi M, Musallam KM, Cappellini MD, Daar S, El-Beshlawy A, Belhoul K, Saned MS, Temraz S, Koussa S, Taher AT. Risk factors for pulmonary hypertension in patients with β thalassemia intermedia. Eur J Intern Med. 2011 Dec;22(6):607-10.
18.Taher A, Elalfy MS, Al Zir K, Daar S, Al Jefri A, Habr D, Kriemler-Krahn U, El-Ali A, Roubert B, El-Beshlawy A. Importance of optimal dosing ≥ 30 mg/kg/d during deferasirox treatment: 2.7-yr follow-up from the ESCALATOR study in patients with β-thalassaemia. Eur J Haematol. 2011 Oct;87(4):355-65.
19. Taher A, Elalfy MS, Al Zir K, Daar S, Al Jefri A, Habr D, Kriemler-Krahn U, Roubert B, El-Beshlawy A. Achieving treatment goals of reducing or maintaining body iron burden with deferasirox in patients with β-thalassaemia: results from the ESCALATOR study. Eur J Haematol. 2011 Oct;87(4):349-54.
20. Daar S, Al Zadjali S, Gravell D, Al Haddabi H, Al Riyami M, Al Belushi A, Berbar T, Krishnamoorthy R. Hb A2' (Hb B2) in the Omani population and diagnostic significance. Hemoglobin. 2011;35(2):117-24.
21. Mohamed SY, Fadhil I, Hamladji RM, Hamidieh AA, Fahmy O, Ladeb S, Alimoghaddam K, Elhaddad A, Nacer RA, Alsharif F, Rasheed W, Jahani M, Mousavi SA, Alseraihy A, Abdel-Rahman F, Al Jefri A, Hussein AA, Alabdulaaly A, Ibrahim A, Bekadja MA, Abboud M, Ahmed P, Dennison D, Bakr M, Benchekroun S, Hussain F, Othman TB, Aljurf M, Ghavamzadeh A. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2008-2009: report on behalf of the Eastern Mediterranean Bone Marrow Transplantation (EMBMT) Group. Hematol Oncol Stem Cell Ther. 2011;4(2):81-93.
22. Ho CH. Can very high level of D-dimer exclusively predict the presence of thromboembolic diseases?J Chin Med Assoc 74(4):151-154, 2011.
23.Al-Riyami AZ, Tsang PW, Hudoba M. Extreme eosinophilia in a setting of metastatic leiomyosarcoma: an unusual case report. Ann Hematol. 2012 Aug;91(8):1323-4.
24. Al-Riyami AZ, Lee J, Connolly M, Shereck E. Cerebral sinus thrombosis following IV immunoglobulin therapy of immune thrombocytopenia purpura. Pediatr Blood Cancer. 2011 Jul 15;57(1):157-9.
25. van Grevenynghe J, Cubas RA, Noto A, DaFonseca S, He Z, Peretz Y, Filali-Mouhim A, Dupuy FP, Procopio FA, Chomont N, Balderas RS, Said EA, Boulassel MR, Tremblay CL, Routy JP, Sékaly RP, Haddad EK. Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosis.J Clin Invest. 2011 Oct;121(10):3877-88.
26. Kamya P, Tsoukas CM, Boulet S, Routy JP, Thomas R, Côté P, Boulassel MR, Lessard B, Kaul R, Ostrowski M, Kovacs C, Tremblay CL, Bernard NF. T cell Activation does not drive CD4 decline in longitudinally followed HIV-infected Elite Controllers. AIDS Res Ther. 2011 Jun 16;8(1):20.
27. Peretz Y, Marra O, Thomas R, Legault D, Côté P, Boulassel MR, Rouleau D, Routy JP, Sékaly RP, Tsoukas CM, Tremblay C, Bernard NF. Relative contribution of HIV-specific functional lymphocyte subsets restricted by protective and non-protective HLA alleles. Viral Immunol. 2011 Jun;24(3):189-98.
28. Pezeshki AM, Côté MH, Azar GA, Routy JP, Boulassel MR, Thibodeau J. Forced expression of HLA-DM at the surface of dendritic cells increases loading of synthetic peptides on MHC class II molecules and modulates T cell responses. J Immunol. 2011 Jul 1;187(1):74-81.
29. Kamya P, Boulet S, Tsoukas CM, Routy JP, Thomas R, Côté P, Boulassel MR, Baril JG, Kovacs C, Migueles SA, Connors M, Suscovich TJ, Brander C, Tremblay CL, Bernard N; Canadian Cohort of HIV Infected Slow Progressors. Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57. J Virol. 2011 Jun;85(12):5949-60.
30. Chamberland A, Sylla M, Boulassel MR, Baril JG, Côté P, Thomas R, Trottier B, Rouleau D, Routy JP, Tremblay C; Investigators of the Primary HIV-Infection Cohort of Montreal. Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infection. Int J STD AIDS. 2011 Mar;22(3):146-50.
31. Monteiro P, Gosselin A, Wacleche VS, El-Far M, Said EA, Kared H, Grandvaux N, Boulassel MR, Routy JP, Ancuta P. Memory CCR6+CD4+ T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin β7. J Immunol. 2011 Apr 15;186(8):4618-30.
32. Bouchentouf M, Forner K, Cuerquis J, Boulassel MR, Routy JP, Waller EK, Quyyumi AA, Paradis P, Schiffrin EL, Galipeau J. A novel and simplified method of culture of human blood-derived early endothelial progenitor cells for the treatment of ischemic vascular disease. Cell Transplant. 2011;20(9):1431-43.
Conference Presentations
1.Panjwani V, Alkindi SS, Fawaz N, & Pathare AV “Prevalence, Spectrum and Correlation of Lupus anticoagulant positivity with Clinical Outcome: Experience from a Single tertiary centre in Oman” Haematologica 96(Suppl 2):663, 2011. (Abstract 1709). 16th Congress of the European Hematology Association. London, United Kingdom, June 9-12, 2011.
2.Pathare AV, Al Zadjali S, Alkindi SS, Panjwani V, Misquith R, AlKhabori, M, Ganguly SS, Paldi A & Krishnamoorthy R “Contribution of Age, Gender, Body Weight, CYP2C9, CYP4F2 and VKORC1 Genotype to the Warfarin Anticoagulant Response in Omani Patients” Haematologica 96(Suppl 2):677, 2011. (Abstract 1751). 16th Congress of the European Hematology Association. London, United Kingdom, June 9-12, 2011.
3.S. Alkindi , S. AlZadjali, A. Pathare and R. Krishnamoorthy “Strategy for Molecular Characterization of Alpha Thalassaemia in Omani Population”. Haematologica 96(Suppl 2):615, 2011. (Abstract 1564). 16th Congress of the European Hematology Association. London, United Kingdom, June 9-12, 2011.
4.S. AlFarsi , S. AlZadjali, V. Kumar, K AlFalahi, D. Gravell, A. Pathare and S. Alkindi . “Inherited Thrombophilia in Women with Recurrent Pregnancy Loss” Haematologica 96 (Suppl 2):670, 2011. (Abstract 1730). 16th Congress of the European Hematology Association. London, United Kingdom, June 9-12, 2011.
5.Ho CH, Gravell D. Setting a target international normalized ratio range doesn’t guarantee good achievement of that range—A study in Omani patients taking warfarin. Haematologica 96(Suppl 2):662, 2011. (Abstract 1704). 16th Congress of the European Hematology Association. London, UK, June 9-12, 2011.
6.AV Pathare, S. AlZadjali, R. Misquith, S. Alkindi, C. Lapoumeroulie, A Paldi, & R. Krishnamoorthy “Atypical VKORC1 haplotypes in the Omani population: Implications for Dose variability of Vitamin K antagonist”. IN VIVO, 25(No.3):552-553,2011.(Abstract. 227). 4th International Congress of Molecular Medicine, Istanbul, Turkey, 27-30 June, 2011.
7.AV Pathare, S. Alkindi, M Al Maskari, S Al Zadjali. & R. Krishnamoorthy “Fetal Hemoglobin expression in Sickle cell disease patients from Oman: Correlation with BCL11A, HBSIL-MYB, HBG2 SNPs”. IN VIVO, 25(No.3):553,2011.(Abstract. 228). 4th International Congress of Molecular Medicine, Istanbul, Turkey, 27-30 June, 2011.
8.Gowri, V, Mathew M, Gravell D, K. Al Falahi, I. Al Zakwani, & AV Pathare, “Protein Z levels in pregnant Omani women: Correlation with pregnancy outcomes” (Abstract-153) XXIIIth Congress of the International Society of Thrombosis & Hemostasis, Kyoto, Japan, 23rd to 28th July, 2011.
9.Chao Hung Ho & Gravell D., Low achievement of target international normalized ratio in patients taking warfarin even in a specialist clinic: A study in Omani patients and review of literature. (Abstract-433) XXIIIth Congress of the International Society of Thrombosis & Hemostasis, Kyoto, Japan, 23rd to 28th July, 2011.
10. V Gowrie, D Dennison, Pathare AV, “Etiological profile of women presenting with premature ovarian failure to Sultan Qaboos University hospital, in the Sultanate of Oman”. (abstract no. 1165079) Presented at The North American Menopause Society (NAMS), 22nd Annual Meeting held between September 21st -24th 2011, in Washington DC, USA.
11. Salam Alkindi, Saba AlMahrooqi, Sumaiya AlHinai, Ali Al Marhoobi, Shahina Daar, Naglaa Fawaz & Pathare AV “Alloimmunization among Patients with Sickle Cell Disease and Thalassaemia: Experience of Single Centre in Oman”, October 22-25, 2011 in San Diego, CA, USA.
12. Shoaib Al Zadjali, Shadhiya Afaq Ahmed Abdulhameed, Saba AlMahrooqi, Salam Alkindi, Aiman Al Wahaibi Pathare AV, “Molecular Basis of Pk Phenotype in a Sickle Cell Anemia Patient from Oman” October 22-25, 2011 in San Diego, CA, USA.
13. Al-Khabori M, Al-Rawas A, Al-Kindi S, et al. Long Term Outcomes of Allogeneic Transplant Using Non-Radiation Based Preparative Regimens for Acute Lymphoblastic Leukemia. Biology of blood and marrow transplantation 2011; 2(supp): S313.
14. Khalil Al Farsi, Murtadha K. Al-Khabori, et al. Gonadal Function In Patients with Beta-Thalassemia Major Following Bone Marrow Transplantation. ASH Annual Meeting Abstracts 2011. 118:4105.
15. Surekha Tony, Murtadha K. Al-Khabori, et al. Dose Optimization of Deferasirox in Chelation Naive Children with Thalassemia Major. ASH Annual Meeting Abstracts 2011. 118:5294.
16. Surekha Tony, Shahina Daar, Shoaib Al Zadjali, Murtadha K. Al-Khabori, et al. T2* MRI in Hypertransfused Children with Thalassemia Intermedia: Serum Ferritin Does Not Reflect the Reality.ASH Annual Meeting Abstracts 2011. 118:5304
17. Khalid Al-Habsi, Murtadha K. Al-Khabori, Muhanna Al-Muslahi, Anil Pathare, Khalil Al Farsi, Mohammed Al Huneini, Sulayma Al Lamki, and Salam Alkindi. Long Term Follow up of Patients with Immune Thrombocytopenia Receiving Rituximab. ASH Annual Meeting Abstracts 2011. 118:4675.
Year of Publication / Number of Scientific papers published in the SQU Journal / Number of scientific papers published in other scientific journals / Number of scientific papers published as a conference proceeding / Number of scientific paper published as a book chapter / Number of scientific papers published as a book2011 / 4 / 28 / 17 / NIL / NIL